NEW YORK (AP) — NEW YORK (AP) — Titan Pharmaceuticals Inc. (TTNP) on Thursday reported a loss of $790,000 in its fourth quarter.
On a per-share basis, the New York-based company said it had a loss of 85 cents.
For the year, the company reported a loss of $4.7 million, or $5.23 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TTNP at https://www.zacks.com/ap/TTNP
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.